Catherine Mezzacappa, MD, MPH

I am a fellow in the Division of Digestive Diseases. My research is focused on better understanding the relationship between metabolic disease (diabetes, fatty liver disease), progression of liver fibrosis, and hepatocellular carcinoma for the purposes of improving clinical risk stratification. I am also interested in the implementation science of screening and early detection of gastrointestinal cancers. Prior to beginning a career in medicine, I completed a Master’s in Public Health (MPH) with a concentration in Epidemiology at Boston University School of Public Health, at which time I was awarded the Dr. Theodore Colton Prize for Excellence in Epidemiology. I then worked in health system program monitoring and evaluation for several international health non-governmental organizations prior to attending medical school at the University of Pennsylvania and then joining the Internal Medicine residency at Yale New Haven Hospital.

Selected publications:

Singh V, Mezzacappa C, Gershkovich P, et al. Systems approach to enhance Lynch syndrome diagnosis through tumour testing. J Med Genet. (2022). https://jmg.bmj.com/content/jmedgenet/early/2022/09/17/jmg-2022-108770.full.pdf

Zhang Y*, Mezzacappa C*, Shen L, et al. Cancer tracking system improves timeliness of liver cancer care at a Veterans Hospital: A comparison of cohorts before and after implementation of an automated care coordination tool. PLOS Digital Health. (2022). https://doi.org/10.1371/journal.pdig.0000080

*Shared first authorship.